---
layout: post
title: "Summit Therapeutics Inc. - 8-K - 8-K"
date: 2026-02-05 21:01:37 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001599298-24-000040
original_published: 2024-03-12 00:00:00 +0000
significance: 10.00
---

# Summit Therapeutics Inc. - 8-K - 8-K

**Published:** February 05, 2026 21:01 UTC
**Source:** SEC EDGAR
**Original Published:** 2024-03-12

## Summary

8-K filing for Summit Therapeutics Inc. (report date 2024-03-12): 8-K

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/smmt-20240312.htm)
- Company: Summit Therapeutics Inc.
- Form type: 8-K
- Accession number: 0001599298-24-000040

## Significance

- Automated score: 10.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
